Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB25FBDV8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,876
Award facts
- Contract value 100% obligated
- $19,875.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,875.72 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 mL vials on August 4, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a non-set-aside, competitively awarded contract. OPDIVO is a brand-name oncology pharmaceutical used for cancer immunotherapy, and this procurement fulfills federal medical supply requirements for military and veteran healthcare systems. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling the company to supply a broad spectrum of pharmaceuticals and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp has demonstrated significant capability in federal pharmaceutical procurement through its extensive portfolio of competitively awarded contracts with the DLA, positioning the company as a critical vendor within the federal medical supply chain for defense and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FBDV8?
SPE2DB25FBDV8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FBDV8 worth?
The government has obligated $19,876 on SPE2DB25FBDV8.
Is contract SPE2DB25FBDV8 an order under another contract?
Yes. SPE2DB25FBDV8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBDV8 competed?
The extent of competition for SPE2DB25FBDV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award